These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35695653)

  • 1. Molecular Targets of Nimbolide for Anti-Cancer Therapy: An Updated Review.
    Elumalai P; Ezhilarasan D; Raghunandhakumar S
    J Environ Pathol Toxicol Oncol; 2022; 41(2):69-88. PubMed ID: 35695653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of Nimbolide and TNF-α-Increases Human Colon Adenocarcinoma Cell Death through JNK-mediated DR5 Up- regulation.
    Chantana C; Yenjai C; Reubroycharoen P; Waiwut P
    Asian Pac J Cancer Prev; 2016; 17(5):2637-41. PubMed ID: 27268643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into Nimbolide molecular crosstalk and its anticancer properties.
    Shaheen S; Khalid S; Aaliya K; Gul A; Hafeez A; Armaghan M; Almarhoon ZM; Calina D; Khan K; Sharifi-Rad J
    Med Oncol; 2024 May; 41(6):158. PubMed ID: 38761317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-proliferative and apoptosis inducing effect of nimbolide by altering molecules involved in apoptosis and IGF signalling via PI3K/Akt in prostate cancer (PC-3) cell line.
    Raja Singh P; Arunkumar R; Sivakamasundari V; Sharmila G; Elumalai P; Suganthapriya E; Brindha Mercy A; Senthilkumar K; Arunakaran J
    Cell Biochem Funct; 2014 Apr; 32(3):217-28. PubMed ID: 23963693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nimbolide, a Neem Limonoid, Inhibits Angiogenesis in Breast Cancer by Abrogating Aldose Reductase Mediated IGF-1/PI3K/Akt Signalling.
    Nivetha R; Arvindh S; Baba AB; Gade DR; Gopal G; K C; Reddy KP; Reddy GB; Nagini S
    Anticancer Agents Med Chem; 2022; 22(14):2619-2636. PubMed ID: 35125086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nimbolide inhibits IGF-I-mediated PI3K/Akt and MAPK signalling in human breast cancer cell lines (MCF-7 and MDA-MB-231).
    Elumalai P; Arunkumar R; Benson CS; Sharmila G; Arunakaran J
    Cell Biochem Funct; 2014 Jul; 32(5):476-84. PubMed ID: 24888707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nimbolide, a Neem Limonoid, Is a Promising Candidate for the Anticancer Drug Arsenal.
    Nagini S; Nivetha R; Palrasu M; Mishra R
    J Med Chem; 2021 Apr; 64(7):3560-3577. PubMed ID: 33739088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of cysteine 179 of IkappaBalpha kinase by nimbolide leads to down-regulation of NF-kappaB-regulated cell survival and proliferative proteins and sensitization of tumor cells to chemotherapeutic agents.
    Gupta SC; Prasad S; Reuter S; Kannappan R; Yadav VR; Ravindran J; Hema PS; Chaturvedi MM; Nair M; Aggarwal BB
    J Biol Chem; 2010 Nov; 285(46):35406-17. PubMed ID: 20829362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nimbolide protects against endotoxin-induced acute respiratory distress syndrome by inhibiting TNF-α mediated NF-κB and HDAC-3 nuclear translocation.
    Pooladanda V; Thatikonda S; Bale S; Pattnaik B; Sigalapalli DK; Bathini NB; Singh SB; Godugu C
    Cell Death Dis; 2019 Jan; 10(2):81. PubMed ID: 30692512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nimbolide, a neem limonoid inhibits Phosphatidyl Inositol-3 Kinase to activate Glycogen Synthase Kinase-3β in a hamster model of oral oncogenesis.
    Sophia J; Kiran Kishore T K; Kowshik J; Mishra R; Nagini S
    Sci Rep; 2016 Feb; 6():22192. PubMed ID: 26902162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nimbolide: promising agent for prevention and treatment of chronic diseases (recent update).
    Rajendran P; Renu K; Abdallah BM; Ali EM; Veeraraghavan VP; Sivalingam K; Rustagi Y; Abdelsalam SA; Ibrahim RIH; Al-Ramadan SY
    Food Nutr Res; 2024; 68():. PubMed ID: 38571915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nimbolide, a limonoid triterpene, inhibits growth of human colorectal cancer xenografts by suppressing the proinflammatory microenvironment.
    Gupta SC; Prasad S; Sethumadhavan DR; Nair MS; Mo YY; Aggarwal BB
    Clin Cancer Res; 2013 Aug; 19(16):4465-76. PubMed ID: 23766363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition.
    Subramani R; Gonzalez E; Arumugam A; Nandy S; Gonzalez V; Medel J; Camacho F; Ortega A; Bonkoungou S; Narayan M; Dwivedi Ak; Lakshmanaswamy R
    Sci Rep; 2016 Jan; 6():19819. PubMed ID: 26804739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nimbolide inhibits androgen independent prostate cancer cells survival and proliferation by modulating multiple pro-survival signaling pathways.
    Singh PR; Priya ES; Balakrishnan S; Arunkumar R; Sharmila G; Rajalakshmi M; Arunakaran J
    Biomed Pharmacother; 2016 Dec; 84():1623-1634. PubMed ID: 27889231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nimbolide induces apoptosis in human nasopharyngeal cancer cells.
    Chien SY; Hsu CH; Lin CC; Chuang YC; Lo YS; Hsi YT; Hsieh MJ; Chen MK
    Environ Toxicol; 2017 Aug; 32(8):2085-2092. PubMed ID: 28383207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nimbolide a limonoid from Azadirachta indica inhibits proliferation and induces apoptosis of human choriocarcinoma (BeWo) cells.
    Harish Kumar G; Chandra Mohan KV; Jagannadha Rao A; Nagini S
    Invest New Drugs; 2009 Jun; 27(3):246-52. PubMed ID: 18719855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nimbolide induces cell death in T lymphoma cells: Implication of altered apoptosis and glucose metabolism.
    Jaiswara PK; Gupta VK; Sonker P; Rawat SG; Tiwari RK; Pathak C; Kumar S; Kumar A
    Environ Toxicol; 2021 Apr; 36(4):628-641. PubMed ID: 33274819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nimbolide retards T cell lymphoma progression by altering apoptosis, glucose metabolism, pH regulation, and ROS homeostasis.
    Jaiswara PK; Kumar A
    Environ Toxicol; 2022 Jun; 37(6):1445-1457. PubMed ID: 35199915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of cell survival and proliferation by nimbolide in human androgen-independent prostate cancer (PC-3) cells: involvement of the PI3K/Akt pathway.
    Raja Singh P; Sugantha Priya E; Balakrishnan S; Arunkumar R; Sharmila G; Rajalakshmi M; Arunakaran J
    Mol Cell Biochem; 2017 Mar; 427(1-2):69-79. PubMed ID: 28025797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer properties of nimbolide and pharmacokinetic considerations to accelerate its development.
    Wang L; Phan DD; Zhang J; Ong PS; Thuya WL; Soo R; Wong AL; Yong WP; Lee SC; Ho PC; Sethi G; Goh BC
    Oncotarget; 2016 Jul; 7(28):44790-44802. PubMed ID: 27027349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.